Related Experiment Video
Updated: May 20, 2025

13:47
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
9.2K
Fibrosis-Related Gene and Protein Expression in Normal and Glaucomatous Trabecular Meshwork Cells.
Yong-Feng Yang1, Paul Holden1, Ying Ying Sun1
1Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States.
Investigative Ophthalmology & Visual Science
|March 24, 2025
Summary
Glaucomatous trabecular meshwork cells show increased fibrotic markers, indicating an endothelial-to-mesenchymal transition (EndMT) phenotype. Cultured GTM cells serve as a valuable model for studying glaucoma fibrosis.
Area of Science:
- Ophthalmology
- Cell Biology
- Biochemistry
Background:
- Glaucomatous trabecular meshwork (GTM) exhibits excessive fibrotic extracellular matrices, impairing aqueous humor outflow.
- Endothelial-to-mesenchymal transition (EndMT) is a key process implicated in tissue fibrosis.
Purpose of the Study:
- To investigate the fibrotic gene and protein profiles of GTM cells compared to non-glaucomatous trabecular meshwork (NTM) cells.
- To determine if GTM cells exhibit characteristics of EndMT.
Main Methods:
- Primary NTM and GTM cells were cultured from human cadaver eyes.
- mRNA profiling using the human fibrosis panel (NanoString), quantitative PCR (qPCR), and Western blotting were performed.
- Matrix metalloproteinase (MMP) activity was assessed using a fluorogenic assay.
Main Results:
- GTM cells showed upregulated EndMT biomarkers (α-SMA, SNAI2, TWISTs, VIM) and increased TGFβ signaling.
- Increased deposition of fibronectin EDA (FN-EDA) and altered integrin expression were observed in GTM cells.
- GTM cells exhibited decreased levels of MMP2, CHI3L1, COL6A3, SERPINF1 proteins but increased MMP activity.
Conclusions:
- Upregulated EndMT markers and altered extracellular matrix components suggest GTM cells undergo EndMT.
- Cultured GTM cells represent a relevant in vitro model for investigating glaucoma-associated fibrosis.

